Annual Drug Patent Expirations for OXBRYTA
Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. It is available from one supplier. There are ten patents protecting this drug.
This drug has two hundred and fifty-two patent family members in forty countries.
The generic ingredient in OXBRYTA is voxelotor. One supplier is listed for this compound. Additional details are available on the voxelotor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
